|
High $0.00 |
Low $0.00 |
Trades 3 |
Turnover $1,511 |
Volume 672,333 |
| 30 June 2023 at 1:49pm | ||||
|
Market Cap (6-Jul) $5,671,263 (1,275th) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 672,333 |
Shortsold (23-Mar) 355,000 (0.00%) (603rd) |
|
52w High $0.077 |
52w Low $0.036 |
P/E - |
EPS 0 |
GTG released this announcement to the ASX on 28 June 2021, 17:37. The announcement is marked as price sensitive, and is 8 page(s) in length and 264.34kb in size.
You can view all announcements from GTG and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from GTG | |
|---|---|
| Notification of cessation of securities - GTG | 10 May 2023, 13:54 |
| Updated Investor Presentation and Investor Webinar | 2 May 2023, 8:59 |
| Publication Validates geneType for Melanoma Risk Assessment | 28 April 2023, 9:02 |
| Response to ASX Query | 28 June 2021, 17:37 |
| US Patent Office Grants Foundational Pharmacogenomic Patent | 11 June 2021, 15:37 |
| GTG COVID-19 Risk Test launched in USA | 1 June 2021, 9:15 |
| Trading Halt | 28 May 2021, 12:00 |
You must be logged in to post a reply.
Genetic Technologies 